(2-{[(2R)-2,3-bis(hexadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
| Title | Journal |
|---|---|
| Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. | Scientific reports 20180101 |
| Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a. | The FEBS journal 20121001 |
| An implicit solvent coarse-grained lipid model with correct stress profile. | The Journal of chemical physics 20100528 |
| Spontaneous transfer of stearic acids between human serum albumin and PEG:2000-grafted DPPC membranes. | European biophysics journal : EBJ 20100501 |
| Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines. | Journal of liposome research 20090101 |
| Specific effect of polyunsaturated fatty acids on the cholesterol-poor membrane domain in a model membrane. | Chemical & pharmaceutical bulletin 20080801 |
| Protein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndrome. | The Cochrane database of systematic reviews 20070718 |
| Exogenous surfactant therapy for ARDS. | Expert opinion on investigational drugs 20060101 |
| A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. | Pediatrics 20050401 |
| Synthetic surfactants: the search goes on. | Pediatrics 20050401 |
| Lucinactant: in neonatal respiratory distress syndrome. | Treatments in respiratory medicine 20050101 |